INMD Stock Recent News

InMode stock has significant upside potential due to its low valuation, profitability, share buybacks, and potential benefits from expected interest rate cuts. INMD's business model involves selling high-quality, expensive medical devices for aesthetic procedures, heavily influenced by interest rates due to customer financing. The stock's decline was driven by underutilized buybacks, declining revenue, and high interest rates, but recent buybacks and potential rate cuts offer a brighter outlook.

YOKNEAM, Israel , Sept. 4, 2024 /PRNewswire/ -- InMode Ltd.

YOKNEAM, Israel , Aug. 6, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences and events in August: 9th Annual Needham Virtual MedTech & Diagnostics Conference Presenters: Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer Format: Virtual one-on-one meetings When: Monday, Aug. 12 Canaccord 44th Annual Global Growth Conference Presenters: Yair Malca, Chief Financial Officer Format: In-person fireside chat moderated by Caitlin Cronin, Director of MedTech Equity Research, and meetings When: Wednesday, Aug. 14 at 2:00 pm ET A live webcast of the presentation can be accessed here.

Start Time: 08:30 January 1, 0000 9:07 AM ET InMode Ltd. (NASDAQ:INMD ) Q2 2024 Earnings Conference Call August 01, 2024, 08:30 AM ET Company Participants Moshe Mizrahy - CEO Michael Kreindel - Co-Founder and Chief Technology Officer Yair Malca - CFO Shakil Lakhani - President, North America Eran Krieger - Medical Director and VP of Medical Affairs Rafael Lickerman - Vice President, Finance Miri Segal - CEO, MS-IR Conference Call Participants Danielle Antalffy - UBS Caitlin Cronin - Canaccord Genuity Jeff Johnson - Baird Joseph Conway - Needham and Company Operator Good day, and welcome to InMode's Second Quarter 2024 Earnings Results Conference Call.

InMode (INMD) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.30 per share. This compares to earnings of $0.72 per share a year ago.

YOKNEAM, Israel, Aug. 1, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter ended June 30, 2024.

IRVINE, Calif. , July 31, 2024 /PRNewswire/ -- InMode Ltd.

InMode (INMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Believes InMode's Cash Balance of Roughly 55% of its Market Cap is Grossly Inefficient Asserts the Current Valuation Offers an Unprecedented Opportunity to Create Shareholder Return MIAMI , July 25, 2024 /PRNewswire/ -- DOMA Perpetual Capital Management LLC today sent a letter to the Board of Directors of InMode (NYSE: INMD) urging the Board to execute a 40% tender offer of the stock.  The letter can be downloaded here.

IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd.